Formulation Development and Evaluation of Tablet Dosage Form for Quick and Protracted Relief in Gastritis and Allied Gastric Disorders
Clicks: 54
ID: 298451
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
15.9
/100
54 views
6 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #10 of 18 articles by views in Current Pharmaceutical Letters And Reviews
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Objective: The object of the current study was to evaluate the tablet's uniqueness in tablet composition with the belief that it would provide both immediate and long-term relief from gastritis and related stomach problems. Method: It was intended to match the batch composition formulae for the core tablets to the potential drug-excipient interaction between Esomeprazole Magnesium and the formulation constituents/excipients of the core and outer tablet. The outer tablets and core tablets were squeezed using a 6.5 mm die punch (concave) set. (without core tablet) were crushed with a 14 mm concave die punch that was adjusted to the ideal compression load and speed. Three batches of tablets were purposed and compressed based on the performance results of the core and outside tablet batches. These batches were then exposed to in vitro release kinetics during the evaluation of the post compression parameters. To predict how the environment would affect the final formulation's quality and to make sure that no changes had been made to the formulation during the manufacturing process, short-term accelerated stability testing of the various tablet batches in tablet formulations was carried out. things can have an adverse effect on its stability. Result and conclusion: With a crushing strength of 3.57, the batch which included sodium starch glycolate as a disintegrant and polyethylene glycol as a binder was the best of all the batches (CT-1 to CT-9), according to the post-compression characteristics of the core tablets. ± 0.115 kg/cm2, a disintegration time of 52.66 ± 0.57 s, a Friability of 0.188 ± 0.002 (percent loss), and a drug content of 100.31 ± 0.32. Out of all batches (OT-1 to OT-9), the OT-2 batch, which contained microcrystalline cellulose as the disintegrant, outperformed the others according to the post-compression parameters of the outer tablet. Its crushing strength was 5.55 ± 0.132 kg/cm2, its friability was 0.098 ± 0.004 (percent loss), and its disintegration time was 161.33 ± 0.57 seconds.
| Reference Key |
imported_1761755562_690241aab65d5
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Krishna Yadav*, Vivek Gupta, Gyan Singh |
| Journal | Current Pharmaceutical Letters And Reviews |
| Year | 2025 |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.